Clinical Outcomes of Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Based on ANCA Type

OBJECTIVE: To evaluate whether the classification of ANCA-associated vasculitis (AAV) patients according to ANCA type (anti-proteinase 3 [PR3] or anti-myeloperoxidase [MPO] antibodies) predicts treatment response. METHODS: Treatment responses were assessed among patients enrolled in the Rituximab in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Unizony, Sebastian, Villarreal, Miguel, Miloslavsky, Eli M., Lu, Na, Merkel, Peter A., Spiera, Robert, Seo, Philip, Langford, Carol A., Hoffman, Gary S., Kallenberg, C.G. M., St. Clair, E. William, Ikle, David, Tchao, Nadia K., Ding, Linna, Brunetta, Paul, Choi, Hyon K., Monach, Paul A., Fervenza, Fernando, Stone, John H., Specks, Ulrich
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4908815/
https://ncbi.nlm.nih.gov/pubmed/26621483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-208073
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados